Optimizing Use of Botulinum Toxin Type A for Pediatric Upper Limb Spasticity: Transforming Science Into Clinical Success

CME: 1.0

August 31, 2020
/ Print / Reprints /
| Share More
/ Text Size+
This interactive enduring activity will cover the management of pediatric patients with upper limb spasticity (ULS).

Post a comment to this article